Bright Minds Biosciences and Its Work
Bright Minds Biosciences, a biotechnology start-up, works to develop drugs that cure mental illness without any side effects. People suffering from mental disorders, addictions, impulsive disorders have to face the side effects of the medicines such as sleeping disorder, weight gain, mood swings and a few others. These side effects work like demotivating factors to the patients and make their condition worse.
The company has a few projects in the pipeline. After completing the required tests and trials, they will drastically change the mental illness drugs sector. The trials on the drugs are promising and positive. BM Biosciences is working to develop drugs for epilepsy, Depression, PTSD, Binge Eating Disorder, Opioid Use Disorder, Alzheimer's and Chronic Pain Disorder. Here is the detail of the Bright Minds Biosciences' work and their concept to develop medicines for the diseases mentioned above.
Bright Minds Biosciences' Work
Bright Minds is in the news for its different approaches to developing medicines to cure mental illness. The biotechnology company is developing drugs that heal the problem without affecting the other parts of the brain. The concept will help the patient to experience medication-free from any side effects. The company is developing pain control medicines, Treatment of epilepsy and Neuropsychiatry.
Bright Minds Biosciences' Pain Control Medicines
Patients suffering from chronic pains develop the symptoms of depression, cognitive impairments and anxiety. These patients consume unapproved psychedelic drugs often to improve pain control. The lack of available options leads chronic pain patients to choose between suffering from pain or highly addictive opioids.
Chronic pain sufferers deserve a safe treatment instead of making a tough choice. So the Bright Minds is working to develop effective and safe non-opioid pain control drugs with the National Institutes of Health to improve their pain and quality of life.
Treatment of epilepsy
Another disease that needs a revolution in its treatment is epilepsy. Approx 60 million people around the globe have this disease. Medicines are available for this mental health issue, but they are not much effective or have major side effects like a few other diseases. Drugs like valproate and carbamazepine are approved to prescribe in epilepsy.
The drugs increase the concentrations of serotonin in the brain and control seizures. The company is developing next-generation serotonin drugs that can accelerate the recovery after seizures and offer protection to the brain.
Neuropsychiatry
The Biotechnology company is working to ameliorated Psilocybin so that the full potential of the compound can be used to treat MDD patients. Its an ambitious project of the company. Patients with MDD and resistance to SSRIs will get better treatment from these next-generation medicines, and that's too without any side effects.
Comments
Post a Comment